Estimate of uncertainty of measurement from a single-laboratory validation study: application to the determination of lead in blood.

BACKGROUND Lead is an environmental pollutant, and human exposure is assessed by monitoring lead concentrations in blood. Because the main source of environmental exposure has been the use of leaded gasoline, its phase-out has led to decreased lead concentrations in the general population. Therefore, validated analytical methods for the determination of lower lead concentrations in blood (<150 microg/L) are needed. In addition, new ISO standards require that laboratories determine and specify the uncertainty of their results. METHODS We validated a method to determine lead in blood at concentrations up to 150 microg/L by electrothermal atomic absorption spectrometry with Zeeman background correction according to EURACHEM guidelines. Blood samples were diluted (1:1 by volume) with 2 mL/L Triton X-100. NH4H2PO4 (5 g/L) and Mg(NO3)2 (0.5 g/L) were used as modifiers. Matrix-matched standards were used for calibration. RESULTS We determined the limits of detection (3.1 microg/L) and quantification (9.4 microg/L). Repeatability and intermediate imprecision within the range 35-150 microg/L were <5.5% and <6.0%, respectively. We assessed trueness by use of certified reference materials, by recovery tests, and by comparison with target values of other reference materials (candidate external quality assessment samples). The expanded uncertainty ranged from 20% to 16% (with a confidence level of 95%) depending on concentration. CONCLUSIONS This study provides a working example of the estimate of uncertainty from method performance data according to the EURACHEM/CITAC guidelines. The estimated uncertainty is compatible with quality specifications for the analysis of lead in blood adopted in the US and the European Union.

[1]  P. Parsons,et al.  A rapid Zeeman graphite furnace atomic absorption spectrometric method for the determination of lead in blood , 1993 .

[2]  L. Scuro,et al.  [Epidemiological observations on leptospirosis in the rice-fields of Sardinia]. , 1962, Rendiconti - Istituto superiore di sanita.

[3]  P. Auinger,et al.  Cognitive deficits associated with blood lead concentrations <10 microg/dL in US children and adolescents. , 2000, Public health reports.

[4]  A. Spiro,et al.  Relations of bone and blood lead to cognitive function: the VA Normative Aging Study. , 1998, Neurotoxicology and teratology.

[5]  K. Hsu,et al.  Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. , 2003, The New England journal of medicine.

[6]  K. S. Subramanian.  Determination of lead in blood by graphite furnace atomic absorption spectrometry--a critique. , 1989, The Science of the total environment.

[7]  G Morisi,et al.  The Italian external quality assessment scheme for trace element analysis in body fluids. , 1996, Annali dell'Istituto superiore di sanita.

[8]  M. Patriarca,et al.  [Characterization of a method for the atomic absorption determination of blood lead using a graphite furnace and the L'vov platform]. , 1982, Annali dell'Istituto superiore di sanita.

[9]  P. Apostoli,et al.  Blood lead reference values: the results of an Italian polycentric study. , 2002, The Science of the total environment.

[10]  J. Kragten,et al.  Tutorial review. Calculating standard deviations and confidence intervals with a universally applicable spreadsheet technique , 1994 .

[11]  E. Sabbioni,et al.  Trace element reference values in tissues from inhabitants of the European Union. X. A study of 13 elements in blood and urine of a United Kingdom population. , 1998, The Science of the total environment.

[12]  G. Lockitch,et al.  Improved sample preparation for accurate determination of low concentrations of lead in whole blood by graphite furnace analysis. , 1991, Clinical chemistry.

[13]  K. Flegal,et al.  The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES) , 1994, JAMA.

[14]  Stephen L. R. Ellison,et al.  The evaluation of measurement uncertainty from method validation studies , 2000 .

[15]  J M Bland,et al.  Statistical methods for assessing agreement between two methods of clinical measurement , 1986 .

[16]  S. Ellison,et al.  Quantifying uncertainty in analytical measurement , 2000 .

[17]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[18]  S. Srivastava,et al.  Environmental exposure to lead as a risk for prostate cancer. , 2002, Biomedical and environmental sciences : BES.

[19]  Stephen L. R. Ellison,et al.  The evaluation of measurement uncertainty from method validation studies. Part 1 : Description of a laboratory protocol , 2000 .

[20]  M. Patriarca,et al.  Determination of low concentrations of potentially toxic elements in human liver from newborns and infants. , 1999, The Analyst.

[21]  J. Links,et al.  The Longitudinal Association of Lead with Blood Pressure , 2003, Epidemiology.

[22]  E W Gunter,et al.  Exposure of the U.S. population to lead, 1991-1994. , 1998, Environmental health perspectives.

[23]  M. Patriarca,et al.  Quality assurance in biological monitoring of environmental exposure to pollutants: from reference materials to external quality assessment schemes , 2000 .

[24]  J. Angerer,et al.  Comparison of procedures for evaluating laboratory performance in external quality assessment schemes for lead in blood and aluminum in serum demonstrates the need for common quality specifications. , 2002, Clinical chemistry.

[25]  P. Parsons,et al.  An assessment of contemporary atomic spectroscopic techniques for the determination of lead in blood and urine matrices , 2001 .

[26]  D. Bannon,et al.  Graphite furnace atomic absorption spectroscopic measurement of blood lead in matrix-matched standards. , 1994, Clinical chemistry.

[27]  J. Kristiansen,et al.  Uncertainty of atomic absorption spectrometry: Application to the determination of lead in blood , 1996 .